ISDA

Deposition Date 2012-04-20

Release Date 2012-05-23

Last Version Date 2024-02-28

Entry Detail

PDB ID:

4ERE

Keywords:

Ligase/Ligase inhibitor

Title:

crystal structure of MDM2 (17-111) in complex with compound 23

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.80 Å

R-Value Free:

0.27

R-Value Work:

0.25

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:E3 ubiquitin-protein ligase Mdm2
Gene (Uniprot):MDM2
Chain IDs:A, B
Chain Length:96
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:Q00987 Pfam ID:PF02201 EC:2.3.2.27

Ligand Molecules

0R2

SO4

Primary Citation

Structure-based design of novel inhibitors of the MDM2-p53 interaction.

Rew, Y, Sun, D, Gonzalez-Lopez De Turiso, F, Bartberger, M.D, Beck, H.P, Canon, J, Chen, A, Chow, D, Deignan, J, Fox, B.M, Gustin, D, Huang, X, Jiang, M, Jiao, X, Jin, L, Kayser, F, Kopecky, D.J, Li, Y, Lo, M.C, Long, A.M, Michelsen, K, Oliner, J.D, Osgood, T, Ragains, M, Saiki, A.Y, Schneider, S, Toteva, M, Yakowec, P, Yan, X, Ye, Q, Yu, D, Zhao, X, Zhou, J, Medina, J.C, Olson, S.H.Show

J.Med.Chem. 55 4936 4954 (2012)

PMID: 22524527 DOI: 10.1021/jm300354j

Abstact

Structure-based rational design led to the discovery of novel inhibitors of the MDM2-p53 protein-protein interaction. The affinity of these compounds for MDM2 was improved through conformational control of both the piperidinone ring and the appended N-alkyl substituent. Optimization afforded 29 (AM-8553), a potent and selective MDM2 inhibitor with excellent pharmacokinetic properties and in vivo efficacy.

Legend

Protein

Chemical

Disease

Primary Citation of related structures